Mechanistically, this molecule binds to TLR2, causes release of Ca2+ and activation of p38, AKT, and NF-κB, thereby polarizing tumor-associated macrophages from a tumor-promoting M2 phenotype into a tumor-killing M1 phenotype (114). The gene discussed is TLR2; the disease is neoplasm.